Lilly to build $2.5 billion diabetes drug plant in Germany

Lilly extends tender offer to acquire Point Biopharma to Dec 1

Eli Lilly: still seeking UK approval on pen for weight-loss drug

Eli Lilly to buy cancer-focused Point Biopharma for $1.4 billion

Eli Lilly settles whistleblower lawsuit over manufacturing problems

US judge overturns Eli Lilly's $176.5 million loss in Teva patent case

Eli Lilly sues over US sales of bogus Mounjaro for weight loss

Nimród Antal on directing Liam Neeson's movie Retribution: 'It was a challenge worth accepting!'

Lilly's obesity drug leads to about 26% weight loss in new studies

Lilly drug slows Alzheimer's by 60% for mildly impaired patients in trial

Uninsured US patients pay up to $330 for Eli Lilly’s $25 insulin, Senator Warren says

Experimental Lilly pill, Mounjaro both lead to 15% weight loss in clinical trials